Prevalence and functional consequence of PHOX2B mutations in neuroblastoma

Raabe, Eric H.; Laudenslager, Marci; Winter, Cynthia; Wasserman, Nora; Cole, Kristina A.; LaQuaglia, Michael J.; Maris, D J; Mossé, Yaël P.; Maris, John M.

doi:10.1038/sj.onc.1210659

Cited by 131 publications

(123 citation statements)

References 16 publications

Supporting

Mentioning

117

Contrasting

Order By: Relevance

“…Finally, many genetic changes have been reported in HSCR and NB patients, and among these, those with the NAPRM PHOX2B mutation represent only a small fraction (7,53). Nonetheless, detailed developmental studies of such rare conditions are important, as lower incidence often correlates with higher physiological impact (e.g., mortality) and because multiple types of the causative gene mutations are likely to converge on a common pathway.…”

Section: Figurementioning

confidence: 99%

Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expression

Nagashimada¹,

Ohta²,

Li³

et al. 2012

J. Clin. Invest.

View full text Add to dashboard Cite

The most common forms of neurocristopathy in the autonomic nervous system are Hirschsprung disease (HSCR), resulting in congenital loss of enteric ganglia, and neuroblastoma (NB), childhood tumors originating from the sympathetic ganglia and adrenal medulla. The risk for these diseases dramatically increases in patients with congenital central hypoventilation syndrome (CCHS) harboring a nonpolyalanine repeat expansion mutation of the Paired-like homeobox 2b (PHOX2B) gene, but the molecular mechanism of pathogenesis remains unknown. We found that introducing nonpolyalanine repeat expansion mutation of the PHOX2B into the mouse Phox2b locus recapitulates the clinical features of the CCHS associated with HSCR and NB. In mutant embryos, enteric and sympathetic ganglion progenitors showed sustained sex-determining region Y (SRY) box10 (Sox10) expression, with impaired proliferation and biased differentiation toward the glial lineage. Nonpolyalanine repeat expansion mutation of PHOX2B reduced transactivation of wild-type PHOX2B on its known target, dopamine β-hydroxylase (DBH), in a dominant-negative fashion. Moreover, the introduced mutation converted the transcriptional effect of PHOX2B on a Sox10 enhancer from repression to transactivation. Collectively, these data reveal that nonpolyalanine repeat expansion mutation of PHOX2B is both a dominant-negative and gain-of-function mutation. Our results also demonstrate that Sox10 regulation by PHOX2B is pivotal for the development and pathogenesis of the autonomic ganglia.

show abstract

Section: Figurementioning

confidence: 99%

Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expression

Nagashimada¹,

Ohta²,

Li³

et al. 2012

J. Clin. Invest.

View full text Add to dashboard Cite

show abstract

“…Mutations in the PHOX2B gene were identified in familial cases of NB and result in tumor predisposition (McConville et al, 2006;Mosse et al, 2004;Trochet et al, 2004;van Limpt et al, 2004). NB PHOX2B mutations affect proliferation and differentiation of embryonic sympathetic neurons and the proliferation of NB cell lines (Raabe et al, 2008;Reiff et al, 2010).…”

Section: Introductionmentioning

confidence: 99%

Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition

et al. 2011

View full text Add to dashboard Cite

SUMMARYNeuroblastoma (NB) is the most common extracranial solid tumor in childhood and arises from cells of the developing sympathoadrenergic lineage. Activating mutations in the gene encoding the ALK tyrosine kinase receptor predispose for NB. Here, we focus on the normal function of Alk signaling in the control of sympathetic neuron proliferation, as well as on the effects of mutant ALK. Forced expression of wild-type ALK and NB-related constitutively active ALK mutants in cultures of proliferating immature sympathetic neurons results in a strong proliferation increase, whereas Alk knockdown and pharmacological inhibition of Alk activity decrease proliferation. Alk activation upregulates NMyc and trkB and maintains Alk expression by an autoregulatory mechanism involving Hand2. The Alk-ligand Midkine (Mk) is expressed in immature sympathetic neurons and in vivo inhibition of Alk signaling by virus-mediated shRNA knockdown of Alk and Mk leads to strongly reduced sympathetic neuron proliferation. Taken together, these results demonstrate that the extent and timing of sympathetic neurogenesis is controlled by Mk/Alk signaling. The predisposition for NB caused by activating ALK mutations may thus be explained by aberrations of normal neurogenesis, i.e. elevated and sustained Alk signaling and increased NMyc expression. Activation of Alk signaling, in particular overexpression of ALK wt and NB ALK mutants resulted in the upregulation of NMyc and trkB, which may contribute to continued proliferation and NB predisposition. MATERIALS AND METHODS Expression plasmidsPcDNA3.1 expression plasmids for human ALK wt , ALK F1174L and ALK R1275Q, and pCAGGS expression plasmids for Hand2, Phox2b wt and Phox2b K155X have been described previously (Janoueix-Lerosey et al., 2008;Reiff et al., 2010). shRNA constructsThe shRNA against Gallus gallus Alk and Mk were designed using BLOCK-iT RNAi Designer (Invitrogen, Karlsruhe, Germany) and target the following sequences: shAlk, 5Ј-AAU GGU UUC UCU CUA UGU CCA ACU C-3Ј; shMk, 5Ј-GAG CUG ACU GCA AGU ACA AGU UUG A-3Ј. Scrambled shRNAs (sc-shRNA, Invitrogen, Karlsruhe, Germany) served as controls. In situ hybridizationNon-radioactive in situ hybridization on cryosections and preparation of digoxigenin labeled probes for chick Phox2b was carried out as described previously (Ernsberger et al., 1997;Stanke et al., 1999). qPCR analysisEqual amounts of RNA were used to synthesize cDNA with Oligo(dT)-primers and Superscript-III-reverse-transcriptase according to manufacturer's instructions (Invitrogen, Karlsruhe, Germany). The PCR was carried out using Abgene's Absolute Blue SYBR-Green qPCR Mix (Abgene, Epsom, UK) in a Stratagene Mx3000p Light Cycler (Stratagene, Waldbronn, Germany). All primers (MWG Biotech AG, Ebersberg, Germany) were designed to anneal optimally at 58°C with PerlPrimer (Marshall, 2004) (95°C for 30 seconds, 58°C for 30 seconds, 72°C for 30 seconds, repeated for 50 cycles and a subsequent dissociation curve). The primer pairs (see Table S1 in the supplementary material) were ...

show abstract

“…The molecular mechanism of the normal development of sympathetic neurons may influence the biology of NB. For example, the homeodomain DNA-binding transcription factor Phox2B is mutated in familial and sporadic forms of NB (12). Phox2B mutations predispose to NB by promoting the proliferation and dedifferentiation of cells in the sympathoadrenergic lineage (13).…”

Section: Introductionmentioning

confidence: 99%

The Neuronal Differentiation Factor NeuroD1 Downregulates the Neuronal Repellent Factor Slit2 Expression and Promotes Cell Motility and Tumor Formation of Neuroblastoma

et al. 2011

View full text Add to dashboard Cite

The basic helix-loop-helix transcription factor NeuroD1 has been implicated in the neurogenesis and early differentiation of pancreatic endocrine cells. However, its function in relation to cancer has been poorly examined. In this study, we found that NeuroD1 is involved in the tumorigenesis of neuroblastoma. NeuroD1 was strongly expressed in a hyperplastic region comprising neuroblasts in the celiac sympathetic ganglion of 2-weekold MYCN transgenic (Tg) mice and was consistently expressed in the subsequently generated neuroblastoma tissue. NeuroD1 knockdown by short hairpin RNA (shRNA) resulted in motility inhibition of the human neuroblastoma cell lines, and this effect was reversed by shRNA-resistant NeuroD1. The motility inhibition by NeuroD1 knockdown was associated with induction of Slit2 expression, and knockdown of Slit2 could restore cell motility. Consistent with this finding, shRNA-resistant NeuroD1 suppressed Slit2 expression. NeuroD1 directly bound to the first and second E-box of the Slit2 promoter region. Moreover, we found that the growth of tumor spheres, established from neuroblastoma cell lines in MYCN Tg mice, was suppressed by NeuroD1 suppression. The functions identified for NeuroD1 in cell motility and tumor sphere growth may suggest a link between NeuroD1 and the tumorigenesis of neuroblastoma. Indeed, tumor formation of tumor sphere-derived cells was significantly suppressed by NeuroD1 knockdown. These data are relevant to the clinical features of human neuroblastoma: high NeuroD1 expression was closely associated with poor prognosis. Our findings establish the critical role of the neuronal differentiation factor NeuroD1 in neuroblastoma as well as its functional relationship with the neuronal repellent factor Slit2. Cancer Res; 71(8); 2938-48. Ó2011 AACR.

show abstract

Prevalence and functional consequence of PHOX2B mutations in neuroblastoma

Cited by 131 publications

References 16 publications

Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expression

Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expression

Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition

The Neuronal Differentiation Factor NeuroD1 Downregulates the Neuronal Repellent Factor Slit2 Expression and Promotes Cell Motility and Tumor Formation of Neuroblastoma

Contact Info

Product

Resources

About